Check the latest price of Beizumifan in 2025, all in one article!
Belzutifan is a HIF-2α inhibitor that is mainly used to treat renal cell carcinoma (RCC), central nervous system hemangioblastoma (CNS-HB) and pancreatic neuroendocrine tumors (pNET) related to VHL gene mutations. Treatment of these indications often presents challenges, especially when conventional therapies are ineffective. By targeting HIF-2α, Bestivan can effectively inhibit tumor growth and slow down the progression of the disease.
In the Chinese market, the price of bezotivan has not been fully disclosed because the drug has just been launched and the specific status of its inclusion in medical insurance is unclear. At present, the price of Bezutivan is relatively expensive in the Hong Kong market. A box of 40mg*90 tablets of the Hong Kong version of the original drug may cost more than 100,000 yuan, which is a considerable burden for many patients. Since Bezutivan requires long-term use, the burden of annual costs is even more obvious.

However, some generic drugs offer more cost-effective options than brand-name drugs. Take the Lao version of the generic version of Besotivan as an example. Its specifications are the same as the original drug, namely 40mg*90 tablets, but the price has dropped significantly, about more than RMB 5,000 per box (affected by exchange rate fluctuations). Although generic drugs are more affordable, their ingredients and efficacy are similar to those of original drugs, making them the choice of some patients. It should be noted that although generic drugs provide economic advantages, patients still need to ensure that the drug is from a formal source when using it to ensure the effectiveness and safety of the treatment.
Overall, the annual cost of besetivan was closely related to the patient's treatment plan. For patients who take medicine for a long time, the high price of medicine will undoubtedly bring a greater financial burden. Therefore, patients need to comprehensively consider factors such as drug price, efficacy, and whether there is medical insurance reimbursement when choosing a treatment plan. With the gradual popularization of the drug and the improvement of medical insurance policies, the price of besetifan may drop, bringing hope to more patients.
Reference materials:https://www.welireg.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)